Home - Products - Cell Cycle/DNA Damage - GPR - NOX-6-18

NOX-6-18

CAS No. 898211-21-7

NOX-6-18( —— )

Catalog No. M37363 CAS No. 898211-21-7

NOX-6-18 (GPR132-B-160) is a highly potent and selective GPR132 antagonist with insulinotropic activity that modulates macrophage reprogramming in pancreatic islets and reduces weight gain.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	164	In Stock
5MG	155	In Stock
10MG	226	In Stock
25MG	377	In Stock
50MG	538	In Stock
100MG	731	In Stock
200MG	1004	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

NOX-6-18
Note

Research use only, not for human use.
Brief Description

NOX-6-18 (GPR132-B-160) is a highly potent and selective GPR132 antagonist with insulinotropic activity that modulates macrophage reprogramming in pancreatic islets and reduces weight gain.
Description

GPR132 antagonist 1 (GPR132-B-160, Compound 25) is a GPR132 antagonist with an EC50 value of 0.075 μM. GPR132 antagonist 1 has promote insulin secretion activity with an EC50 value of 0.7 μM.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Cell Cycle/DNA Damage
Target

GPR
Recptor

GPR
Research Area

——
Indication

——

Chemical Information

CAS Number

898211-21-7
Formula Weight

359.4
Molecular Formula

C18H17NO5S
Purity

>98% (HPLC)
Solubility

——
SMILES

O=C(O)C=1OC=2C=CC(=CC2C1C)S(=O)(=O)NCCC=3C=CC=CC3
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

ML401

ML401 is a selectively EBI2(GPR183) receptor antagonist(IC50 of 1.03 nM) .
GLPG1205

GLPG1205 is a potent, orally active GPR84 (G protein-coupled receptor) antagonist with anti-inflammatory activity. GLPG1205 shows good PK/PD characteristics and can be used to study pulmonary fibrosis.
CVN424

CVN424 is a selective and novel GPR6 Inverse agonist effective in models of Parkinson Disease.

Sign In Join Free